{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:41:43Z","timestamp":1789468903707,"version":"build-2803163510"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000106","name":"Saskatchewan Health Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000106","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NanoImpact"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.impact.2021.100299","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T18:42:46Z","timestamp":1611859366000},"page":"100299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance"],"prefix":"10.1016","volume":"21","author":[{"given":"Sana","family":"Daneshamouz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubong","family":"Eduok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Abdelrasoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shoker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.impact.2021.100299_bb0005","series-title":"2011 annual report: Treatment of endstage organ failure in Canada. CORR Reports","author":"Canadian Organ Replacement Register","year":"2011"},{"key":"10.1016\/j.impact.2021.100299_bb0020","doi-asserted-by":"crossref","first-page":"E417","DOI":"10.1503\/cmaj.120833","article-title":"Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey","volume":"185","author":"Arora","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.impact.2021.100299_bb0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.ajkd.2004.04.033","article-title":"Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study","volume":"44","author":"Bammens","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.impact.2021.100299_bb0030","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/j.1875-9114.1990.tb02584.x","article-title":"Liver function assessment by drug metabolism","volume":"10","author":"Barstow","year":"1990","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.impact.2021.100299_bb0035","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1021\/jp9059517","article-title":"Binding of p-cresyl sulfate and p-cresol to human serum albumin studied by microcalorimetry","volume":"114","author":"Berg\u00e9-Lefranc","year":"2010","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.impact.2021.100299_bb0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.micromeso.2011.11.024","article-title":"In vitro elimination of protein bound uremic toxin p-cresol by MFI-type zeolites","volume":"153","author":"Berg\u00e9-Lefranc","year":"2012","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.impact.2021.100299_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0009-8981(97)00117-4","article-title":"Binding of indole-3-acetic acid to human serum albumin and competition with L-tryptophan","volume":"265","author":"Bertuzzi","year":"1997","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.impact.2021.100299_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MAT.0000000000000166","article-title":"Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration","volume":"61","author":"B\u00f6hringer","year":"2015","journal-title":"ASAIO J."},{"issue":"2","key":"10.1016\/j.impact.2021.100299_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/ndt\/gfg508","article-title":"Which dialyser membrane to choose?","volume":"19","author":"Boure","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.impact.2021.100299_bb0060","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1021\/ja408505n","article-title":"Nanoscale structure\u2013activity relationships, mode of action, and biocompatibility of gold nanoparticle antibiotics","volume":"136","author":"Bresee","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.impact.2021.100299_bb0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1525-1594.2012.01570.x","article-title":"Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique","volume":"37","author":"Brettschneider","year":"2013","journal-title":"Artif. Organs"},{"key":"10.1016\/j.impact.2021.100299_bb0070","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.arrt.2003.08.002","article-title":"Protein-bound uremic retention solutes","volume":"10","author":"Brunet","year":"2003","journal-title":"Adv. Ren. Replace. Ther."},{"key":"10.1016\/j.impact.2021.100299_bb0075","article-title":"Size controlled synthesis of biocompatible gold nanoparticles and their activity in the oxidation of NADH","volume":"23","author":"Chandran","year":"2011","journal-title":"Nanotechnology."},{"key":"10.1016\/j.impact.2021.100299_bb0080","doi-asserted-by":"crossref","first-page":"19691","DOI":"10.1021\/acsami.6b05905","article-title":"Multifunctions of excited gold nanoparticles decorated artificial kidney with efficient hemodialysis and therapeutic potential","volume":"8","author":"Chen","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.impact.2021.100299_bb0085","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/nl052396o","article-title":"Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells","volume":"6","author":"Chithrani","year":"2006","journal-title":"Nano Lett."},{"key":"10.1016\/j.impact.2021.100299_bb0090","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000502331","article-title":"Uremic toxins and their relation to Dialysis efficacy","volume":"48","author":"Clark","year":"2019","journal-title":"Blood Purif."},{"key":"10.1016\/j.impact.2021.100299_bb0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.ajkd.2014.02.016","article-title":"Acute hemodynamic response and uremic toxin removal in conventional and extended hemodialysis and Hemodiafiltration: a randomized crossover study","volume":"64","author":"Cornelis","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.impact.2021.100299_bb0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biochi.2017.05.010","article-title":"Exploring binding characteristics and the related competition of different protein-bound uremic toxins","volume":"139","author":"Deltombe","year":"2017","journal-title":"Biochimie."},{"key":"10.1016\/j.impact.2021.100299_bb0105","series-title":"Uremic Toxicity: Urea and beyond","first-page":"246","author":"Depner","year":"2001"},{"key":"10.1016\/j.impact.2021.100299_bb0110","doi-asserted-by":"crossref","unstructured":"Devuyst, O., Westrhenen, R., Topley, N., 2009. Long-term peritoneal dialysis patients. Nolph and Gokal's textbook of peritoneal dialysis. Boston, MA, USA: springer, p. 757\u2013780.","DOI":"10.1007\/978-0-387-78940-8_27"},{"key":"10.1016\/j.impact.2021.100299_bb0115","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.impact.2021.100299_bb0120","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1093\/ndt\/gfs367","article-title":"What can the dialysis physician learn from kinetic modelling beyond Kt\/V(urea)?","volume":"27","author":"Eloot","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.impact.2021.100299_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147159","article-title":"Protein-bound uremic toxin profiling as a tool to optimize hemodialysis","volume":"11","author":"Eloot","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.impact.2021.100299_bb0130","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.kint.2017.06.029","article-title":"P-cresol sulfate and indoxyl sulfate: some clouds are gathering in the uremic toxin sky","volume":"92","author":"Evenepoel","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.impact.2021.100299_bb0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jff.2014.01.018","article-title":"Selection of uremic toxin-reducing probiotics in vitro and in vivo","volume":"7","author":"Fang","year":"2014","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.impact.2021.100299_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2017.09.018","article-title":"Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream?","volume":"144","author":"Florens","year":"2018","journal-title":"Biochimie."},{"key":"10.1016\/j.impact.2021.100299_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins12040234","article-title":"Protein-bound uremic toxins in hemodialysis patients relate to residual kidney function, are not influenced by convective transport, and do not relate to outcome","volume":"12","author":"van Gelder","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.impact.2021.100299_bb0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00332566","article-title":"Insights into the mechanism of gold action provided by immunotoxicology: biooxidation of gold (I) to gold (III) detected by sensitized T-cells","volume":"11","author":"Gleichmann","year":"1991","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.impact.2021.100299_bb0155","series-title":"New Uremic Toxins\u2013Which Solutes Should Be Removed?","first-page":"117","author":"Glorieux","year":"2011"},{"key":"10.1016\/j.impact.2021.100299_bb0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10715769009149889","article-title":"Control of oxidative damage in rheumatoid arthritis by gold (I)-thiolate drugs","volume":"10","author":"Grootveld","year":"1990","journal-title":"Free Radic. Res. Commun."},{"issue":"2","key":"10.1016\/j.impact.2021.100299_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1289\/ehp.8284","article-title":"A Toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factor","volume":"114","author":"Hardman","year":"2006","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.impact.2021.100299_bb0170","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/smll.200900626","article-title":"In vivo quantum-dot toxicity assessment","volume":"6","author":"Hauck","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.impact.2021.100299_bb0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archoto.2010.62","article-title":"Biofilm detection with hematoxylin-eosin staining","volume":"136","author":"Hochstim","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"10.1016\/j.impact.2021.100299_bb0180","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10157-018-1641-8","article-title":"Clinical epidemiology of infectious disease among patients with chronic kidney disease","volume":"23","author":"Ishigami","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.impact.2021.100299_bb0185","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00216-012-5929-3","article-title":"Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography\/tandem mass spectrometry and their effects on endothelial ROS production","volume":"403","author":"Itoh","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.impact.2021.100299_bb0190","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1042\/CS20160191","article-title":"Disposition and clinical implications of protein-bound uremic toxins","volume":"131","author":"Jansen","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.impact.2021.100299_bb0195","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.impact.2021.100299_bb0200","series-title":"Progress in Uremic Toxin Research: Protein-Bound Toxins\u2014Update 2009. Seminars in dialysis","first-page":"334","author":"Jourde-Chiche","year":"2009"},{"key":"10.1016\/j.impact.2021.100299_bb0205","series-title":"Vascular Incompetence in Dialysis Patients\u2014Protein-Bound Uremic Toxins and Endothelial Dysfunction. Seminars in dialysis","first-page":"327","author":"Jourde-Chiche","year":"2011"},{"key":"10.1016\/j.impact.2021.100299_bb0210","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/ki.1994.221","article-title":"Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis","volume":"45","author":"Kabanda","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.impact.2021.100299_bb0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tiv.2016.08.013","article-title":"Biocompatibility of gold nanoparticles in retinal pigment epithelial cell line","volume":"37","author":"Karako\u00e7ak","year":"2016","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.impact.2021.100299_bb0220","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.impact.2021.100299_bb0225","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1021\/jacs.8b12525","article-title":"Zirconium-based metal\u2013organic frameworks for the removal of protein-bound uremic toxin from human serum albumin","volume":"141","author":"Kato","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"87","key":"10.1016\/j.impact.2021.100299_bb0230","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1046\/j.1523-1755.64.s87.14.x","article-title":"Serum albumin concentration in dialysis patients: why does it remain resistant to therapy?","volume":"87","author":"Kaysen","year":"2003","journal-title":"Kidney Int. Suppl."},{"issue":"8","key":"10.1016\/j.impact.2021.100299_bb0235","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1158\/1078-0432.CCR-04-2626","article-title":"Progress and promise of FDG-PET imaging for Cancer patient management and oncologic drug development","volume":"11","author":"Kelloff","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.impact.2021.100299_bb0240","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/ndt\/gfr616","article-title":"Albumin-binding capacity (ABiC) is reduced in patients with chronic kidney disease along with an accumulation of protein-bound uraemic toxins","volume":"27","author":"Klammt","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.impact.2021.100299_bb0245","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/1522-2594(200103)45:3<454::AID-MRM1060>3.0.CO;2-M","article-title":"3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties","volume":"45","author":"Kobayashi","year":"2001","journal-title":"Magn Reason Med."},{"key":"10.1016\/j.impact.2021.100299_bb0250","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ndt\/gfp437","article-title":"Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration","volume":"25","author":"Krieter","year":"2009","journal-title":"Nephrol Dial Transpl."},{"key":"10.1016\/j.impact.2021.100299_bb0255","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jiec.2015.09.001","article-title":"Optimization conditions for oxalic acid pretreatment of deacetylated yellow poplar for ethanol production","volume":"32","author":"Kundu","year":"2015","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/j.impact.2021.100299_bb0260","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.memsci.2015.04.009","article-title":"Electrospun nanofibrous cellulose diacetate nitrate membrane for protein separation","volume":"489","author":"Lan","year":"2015","journal-title":"J. Membr. Sci."},{"issue":"3","key":"10.1016\/j.impact.2021.100299_bb0265","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1039\/C2CS35392J","article-title":"Nanotoxicity assessment of quantum dots: from cellular to primate studies","volume":"42","author":"Yong","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.impact.2021.100299_bb0270","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/CIRCRESAHA.112.278457","article-title":"Cardiorenal syndrome: the emerging role of protein-bound uremic toxins","volume":"111","author":"Lekawanvijit","year":"2012","journal-title":"Circ. Res"},{"key":"10.1016\/j.impact.2021.100299_bb0275","doi-asserted-by":"crossref","first-page":"F52","DOI":"10.1152\/ajprenal.00348.2015","article-title":"Protein-bound uremic toxins: a long overlooked culprit in cardiorenal syndrome","volume":"311","author":"Lekawanvijit","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.impact.2021.100299_bb0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ndt\/15.1.50","article-title":"Intradialytic removal of protein-bound uremic toxins: role of solute characteristics and of dialyzer membrane","volume":"15","author":"Lesaffer","year":"2000","journal-title":"Neph Dial Transp."},{"key":"10.1016\/j.impact.2021.100299_bb0285","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ndt\/15.1.50","article-title":"Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane","volume":"15","author":"Lesaffer","year":"2000","journal-title":"Nephrol Dial Transpl."},{"key":"10.1016\/j.impact.2021.100299_bb0290","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.phymed.2018.12.018","article-title":"Improved dialysis removal of protein-bound uremic toxins by salvianolic acids","volume":"57","author":"Li","year":"2019","journal-title":"Phytomedicine."},{"key":"10.1016\/j.impact.2021.100299_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067168","article-title":"Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?","volume":"8","author":"Liabeuf","year":"2013","journal-title":"PLoS one"},{"key":"10.1016\/j.impact.2021.100299_bb0300","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1042\/CS20160393","article-title":"Protein-bound toxins: has the Cinderella of uraemic toxins turned into a princess?","volume":"130","author":"Liabeuf","year":"2016","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.impact.2021.100299_bb0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1440-1797.2006.00745.x","article-title":"Impairments of the biological properties of serum albumin in patients on haemodialysis","volume":"12","author":"Lim","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.impact.2021.100299_bb0310","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijge.2011.04.010","article-title":"Serum concentration of p-cresol and indoxyl sulfate in elderly hemodialysis patients","volume":"5","author":"Lin","year":"2011","journal-title":"Int. J. Gerontol."},{"key":"10.1016\/j.impact.2021.100299_bb0315","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuro.2019.02.019","article-title":"Indole-3 acetic acid increased risk of impaired cognitive function in patients receiving hemodialysis","volume":"73","author":"Lin","year":"2019","journal-title":"Neurotoxicology."},{"key":"10.1016\/j.impact.2021.100299_bb0320","series-title":"Physiology","first-page":"212","article-title":"Urine formation and excretion","author":"Liu","year":"2008"},{"issue":"3","key":"10.1016\/j.impact.2021.100299_bb0325","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nucmedbio.2008.12.011","article-title":"Biodistribution, pharmacokinetics and PET imaging of [18F] FMISO, [18F] FDG and [18F]FAc in a sarcoma- and inflammation-bearing mouse model","volume":"36","author":"Liu","year":"2009","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.impact.2021.100299_bb0330","first-page":"85","article-title":"Carbon nanotubes in biology and medicine: In vitro and in vivo detection","volume":"2","author":"Liu","year":"2009","journal-title":"Imaging and Drug Delivery Nano Res."},{"key":"10.1016\/j.impact.2021.100299_bb0335","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.mattod.2013.11.003","article-title":"Renal clearable inorganic nanoparticles: a new frontier of bionanotechnology","volume":"16","author":"Liu","year":"2013","journal-title":"Mater. Today"},{"key":"10.1016\/j.impact.2021.100299_bb0340","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/toxins10090367","article-title":"Impacts of indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120","volume":"10","author":"Liu","year":"2018","journal-title":"Toxins."},{"issue":"5","key":"10.1016\/j.impact.2021.100299_bb0345","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/17435889.3.5.703","article-title":"Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats","volume":"3","author":"Longmire","year":"2008","journal-title":"Nanomedicine-UK"},{"key":"10.1016\/j.impact.2021.100299_bb0350","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/0720-048X(94)90090-6","article-title":"Pharmacokinetics and tissue distribution of iomeprol in animals","volume":"18","author":"Lorusso","year":"1994","journal-title":"Eur. J. Radiol."},{"issue":"6","key":"10.1016\/j.impact.2021.100299_bb0355","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00004424-200106000-00002","article-title":"Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis","volume":"36","author":"Lorusso","year":"2001","journal-title":"Investig. Radiol."},{"issue":"3","key":"10.1016\/j.impact.2021.100299_bb0360","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.kint.2016.09.052","article-title":"Residual renal function: a paradigm shift","volume":"91","author":"Lowenstein","year":"2017","journal-title":"Kidney Int."},{"issue":"10371","key":"10.1016\/j.impact.2021.100299_bb0365","first-page":"1","article-title":"A Novel Mathematical Model of Protein-Bound Uremic Toxin Kinetics during Hemodialysis","volume":"7","author":"Maheshwari","year":"2017","journal-title":"Sci Rep"},{"issue":"909","key":"10.1016\/j.impact.2021.100299_bb0370","first-page":"1","article-title":"In silico comparison of proteinbound uremic toxin removal by hemodialysis, hemodiafltration, membrane adsorption, and binding competition","volume":"9","author":"Maheshwari","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.impact.2021.100299_bb0375","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.2215\/CJN.03150318","article-title":"Characteristics of colon-derived uremic solutes","volume":"13","author":"Mair","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.impact.2021.100299_bb0380","first-page":"375","article-title":"Technetium-99m DADS complexes as renal function and imaging agents: II. Biological comparison with iodine-131 hippuran","volume":"26","author":"McAfee","year":"1985","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.impact.2021.100299_bb0385","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/ndt\/gfn522","article-title":"Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial","volume":"24","author":"Meert","year":"2008","journal-title":"Nephrol Dial Transpl."},{"key":"10.1016\/j.impact.2021.100299_bb0390","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1093\/ndt\/gfq803","article-title":"Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities","volume":"26","author":"Meert","year":"2011","journal-title":"Nephrol Dial Transpl."},{"issue":"5","key":"10.1016\/j.impact.2021.100299_bb0395","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1053\/j.ajkd.2007.12.035","article-title":"A review of albumin binding in CKD","volume":"51","author":"Meijers","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.impact.2021.100299_bb0400","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.2215\/CJN.02940509","article-title":"P-Cresyl sulfate and indoxyl sulfate in hemodialysis patients","volume":"4","author":"Meijers","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.impact.2021.100299_bb0405","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000330176","article-title":"Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis","volume":"34","author":"Meijers","year":"2011","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.impact.2021.100299_bb0410","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1523-1755.2005.00469.x","article-title":"The clearance of protein-bound solutes by hemofiltration and hemodiafiltration","volume":"68","author":"Meyer","year":"2005","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.impact.2021.100299_bb0415","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/039139880302601006","article-title":"Platelet loss across the hemofilter during continuous hemofiltration","volume":"26","author":"Mulder","year":"2003","journal-title":"Int J Artificial Organs."},{"key":"10.1016\/j.impact.2021.100299_bb0420","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.taap.2005.01.008","article-title":"Respiratory toxicity of multi-wall carbon nanotubes","volume":"207","author":"Muller","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.impact.2021.100299_bb0425","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1021\/nl9042483","article-title":"Biocompatible Nanoscale dispersion of single-walled carbon nanotubes minimizes in vivo pulmonary toxicity","volume":"10","author":"Mutlu","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.impact.2021.100299_bb0430","first-page":"1","article-title":"Resolution of dialyzer membrane-associated thrombocytopenia with use of cellulose triacetate membrane: a case report. Case rep med","volume":"134295","author":"Olafiranye","year":"2011","journal-title":"Article ID"},{"key":"10.1016\/j.impact.2021.100299_bb0435","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/17458080.2010.514952","article-title":"Synthesis, characterisation and biocompatibility of surface-functionalised gold nanoparticles","volume":"7","author":"Raji","year":"2012","journal-title":"J. Exp. Nanosci."},{"issue":"21","key":"10.1016\/j.impact.2021.100299_bb0440","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1093\/bioinformatics\/bty419","article-title":"NGL viewer: webbased molecular graphics for large complexes","volume":"34","author":"Rose","year":"2018","journal-title":"Bioinformatics."},{"key":"10.1016\/j.impact.2021.100299_bb0445","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/femsec\/fiy125","article-title":"Identification of phenol-and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites","volume":"94","author":"Saito","year":"2018","journal-title":"FEMS Microbiol. Ecol."},{"key":"10.1016\/j.impact.2021.100299_bb0450","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/aa6546","article-title":"A haemocompatible and scalable nanoporous adsorbent monolith synthesised using a novel lignin binder route to augment the adsorption of poorly removed uraemic toxins in haemodialysis","volume":"12","author":"Sandeman","year":"2017","journal-title":"Biomed. Mater."},{"issue":"Suppl. 1","key":"10.1016\/j.impact.2021.100299_bb0455","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US renal data system 2018 annual data report: epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.impact.2021.100299_bb0460","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000320765","article-title":"Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation","volume":"30","author":"Schepers","year":"2010","journal-title":"Blood Purif."},{"key":"10.1016\/j.impact.2021.100299_bb0465","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.onano.2017.07.001","article-title":"Recent trends and methodologies in gold nanoparticle synthesis\u2013a prospective review on drug delivery aspect","volume":"2","author":"Sengani","year":"2017","journal-title":"OpenNano."},{"key":"10.1016\/j.impact.2021.100299_bb0470","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1039\/B612972B","article-title":"Improved biocompatibility of surface functionalized dendrimer-entrapped gold nanoparticles","volume":"3","author":"Shi","year":"2006","journal-title":"Soft Matter"},{"issue":"5","key":"10.1016\/j.impact.2021.100299_bb0475","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/aor.13383","article-title":"Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis","volume":"43","author":"Shi","year":"2018","journal-title":"Artif. Organs"},{"issue":"4","key":"10.1016\/j.impact.2021.100299_bb0480","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000495343","article-title":"Effect of ionic strength, pH, and chemical displacers on the percentage protein binding of protein-bound uremic toxins","volume":"47","author":"Shi","year":"2019","journal-title":"Blood Purif."},{"key":"10.1016\/j.impact.2021.100299_bb0485","doi-asserted-by":"crossref","first-page":"10644","DOI":"10.1021\/la0513712","article-title":"Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview","volume":"21","author":"Shukla","year":"2005","journal-title":"Langmuir."},{"key":"10.1016\/j.impact.2021.100299_bb0490","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/S0142-9612(00)00149-6","article-title":"Biomaterial\u2013microvasculature interactions","volume":"21","author":"Sieminski","year":"2000","journal-title":"Biomaterials."},{"key":"10.1016\/j.impact.2021.100299_bb0495","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/19430892.2011.633479","article-title":"Cytotoxicity and cellular internalization studies of biogenic gold nanotriangles in animal cell lines","volume":"3","author":"Singh","year":"2011","journal-title":"Int J Green Nanotechnol."},{"key":"10.1016\/j.impact.2021.100299_bb0500","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.kint.2016.11.002","article-title":"Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the frequent hemodialysis network daily trial","volume":"91","author":"Sirich","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.impact.2021.100299_bb0505","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/ndt\/gfr691","article-title":"Selectively increasing the clearance of protein-bound uremic solutes","volume":"27","author":"Sirich","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.impact.2021.100299_bb0510","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2013060597","article-title":"Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion","volume":"25","author":"Sirich","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.impact.2021.100299_bb0515","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semnephrol.2014.02.004","article-title":"Protein-bound molecules: a large family with a bad character","volume":"34","author":"Sirich","year":"2014","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.impact.2021.100299_bb0520","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2672.1996.tb04331.x","article-title":"Enumeration of human colonic bacteria producing phenolic and indolic compounds: Effect of pH, carbohydrate availability and retention time on dissmilatory aromatic amino acid metabolism","volume":"81","author":"Smith","year":"1996","journal-title":"J Appl Bacteriology"},{"issue":"6","key":"10.1016\/j.impact.2021.100299_bb0525","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0026-895X(25)10855-9","article-title":"Further characterization of specific drug binding sites on human serum albumin","volume":"12","author":"Sudlow","year":"1976","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.impact.2021.100299_bb0530","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/protein\/12.6.439","article-title":"Crystal structure of human serum albumin at 2.5 a resolution","volume":"12","author":"Sugio","year":"1999","journal-title":"Protein Eng."},{"key":"10.1016\/j.impact.2021.100299_bb0535","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bone.2013.07.002","article-title":"P-Cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways","volume":"56","author":"Tanaka","year":"2013","journal-title":"Bone"},{"issue":"23389","key":"10.1016\/j.impact.2021.100299_bb0540","first-page":"1","article-title":"Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study","volume":"6","author":"Tao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.impact.2021.100299_bb0545","first-page":"56","article-title":"All about albumin: biochemistry, genetics, and medical applications","author":"Theodore","year":"1995","journal-title":"Academic Press. p"},{"key":"10.1016\/j.impact.2021.100299_bb0550","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1016\/j.biomaterials.2013.07.008","article-title":"Mixed matrix hollow fber membranes for removal of protein-bound toxins from human plasma","volume":"34","author":"Tijink","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.impact.2021.100299_bb0555","series-title":"Chronic Kidney Disease: Definition, Classification, and Approach to Management. In: Turner NN, Et al., Editors. Oxford Textbook of Nephrology. 4th Edition","first-page":"90","author":"Upadhyay","year":"2015"},{"key":"10.1016\/j.impact.2021.100299_bb0560","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1046\/j.1523-1755.2001.59780266.x","article-title":"Protein-bound uremic solutes: the forgotten toxins","volume":"59","author":"Vanholder","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.impact.2021.100299_bb0565","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1046\/j.1523-1755.63.s84.43.x","article-title":"New insights in uremic toxins","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.impact.2021.100299_bb0570","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.impact.2021.100299_bb0575","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.jrn.2011.10.026","article-title":"An update on protein-bound uremic retention solutes","volume":"22","author":"Vanholder","year":"2012","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.impact.2021.100299_bb0580","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/bdd.1834","article-title":"Albumin is the main plasma binding protein for indoxyl sulfate and p-cresyl sulfate","volume":"34","author":"Viaene","year":"2013","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.impact.2021.100299_bb0585","doi-asserted-by":"crossref","unstructured":"Wang H.E., Wu S.Y., Chang C.W., Liu R.S, Hwang L.C., Lee T.W., Chen J.C., Hwang J.J., 2005. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model. Nucl. Med. Biol. 32 (4), 367\u2013370.","DOI":"10.1016\/j.nucmedbio.2005.01.005"},{"key":"10.1016\/j.impact.2021.100299_bb0590","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/toxsci\/kfg228","article-title":"Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats","volume":"77","author":"Warheit","year":"2004","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.impact.2021.100299_bb0595","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/jps.22592","article-title":"Update on the pharmacokinetics and redox properties of proteinbound uremic toxins","volume":"100","author":"Watanabe","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.impact.2021.100299_bb0600","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1124\/dmd.112.045617","article-title":"Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin","volume":"40","author":"Watanabe","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.impact.2021.100299_bb0605","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jbiotec.2005.11.009","article-title":"Adsorption of the uremic toxin p-cresol onto hemodialysis membranes and microporous adsorbent zeolite silicalite","volume":"123","author":"Wernert","year":"2006","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.impact.2021.100299_bb0610","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.micromeso.2005.03.018","article-title":"Adsorption properties of zeolites for artificial kidney applications","volume":"83","author":"Wernert","year":"2005","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.impact.2021.100299_bb0615","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"P-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2010","journal-title":"Nephrol Dial Transpl."},{"key":"10.1016\/j.impact.2021.100299_bb0620","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1007\/s12010-014-1193-7","article-title":"Influence of reducing agents on biosafety and biocompatibility of gold nanoparticles","volume":"174","author":"Xia","year":"2014","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.impact.2021.100299_bb0625","doi-asserted-by":"crossref","unstructured":"Yamamoto S., Kazama J.J, Wakamatsu T., Takahashi Y., Kaneko Y., Goto S., Narita I., 2016. Removal of uremic toxins by renal replacement therapies: a review of current progress and future perspectives. Renal Replace Ther. 2(43), 1\u20138.","DOI":"10.1186\/s41100-016-0056-9"},{"key":"10.1016\/j.impact.2021.100299_bb0630","series-title":"Reviews: Uremic Toxins: A New Focus on an Old Subject","first-page":"203","author":"Yavuz","year":"2005"},{"key":"10.1016\/j.impact.2021.100299_bb0635","series-title":"Toxicological Considerations of Clinically Applicable Nanoparticles Nano Today 6, 585\u2013607","author":"Yildirimer","year":"2011"},{"key":"10.1016\/j.impact.2021.100299_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtice.2019.11.007","article-title":"Preparation of porous phosphine oxide-incorporated polymer membranes for selective removal of p-cresol from simulated serum: a preliminary study","volume":"107","author":"Yu","year":"2020","journal-title":"J Taiwan Inst Chem E."},{"issue":"23","key":"10.1016\/j.impact.2021.100299_bb0645","doi-asserted-by":"crossref","first-page":"8230","DOI":"10.1158\/1078-0432.CCR-05-1895","article-title":"Liposomal, nanoparticle, and conjugated formulations of anticancer agents","volume":"11","author":"Zamboni","year":"2005","journal-title":"Clin. Cancer Res."}],"container-title":["NanoImpact"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452074821000082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452074821000082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:32:16Z","timestamp":1762529536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452074821000082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":127,"alternative-id":["S2452074821000082"],"URL":"https:\/\/doi.org\/10.1016\/j.impact.2021.100299","relation":{},"ISSN":["2452-0748"],"issn-type":[{"value":"2452-0748","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance","name":"articletitle","label":"Article Title"},{"value":"NanoImpact","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.impact.2021.100299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100299"}}